Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.
Rashidi A, Ebadi M, Said B, Cao Q, Shanley R, Curtsinger J, Bejanyan N, Warlick ED, Green JS, Brunstein CG, Miller JS, Weisdorf DJ.
Rashidi A, et al. Among authors: ebadi m.
Am J Hematol. 2018 May 14:10.1002/ajh.25141. doi: 10.1002/ajh.25141. Online ahead of print.
Am J Hematol. 2018.
PMID: 29756385
Free PMC article.